Lipids and cardiovascular diseases

Canadian Journal of Cardiology

Volumn 15, Issue SUPPL. G, 1999, Pages

  Sniderman, Allan D ^a   Frohlich, Jiri ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; CARDIOVASCULAR DISEASE; HUMAN; HYPERLIPIDEMIA; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; RISK FACTORS;

EID: 0033252648     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Brensike JF, Levy RI, Kelsey SF, et al. Effects of therapy and cholestyramine on progression of coronary atherosclerosis: Results of the NHLBI Type II Coronary Intervention Study. Circulation 1984;69:313-24.
2. Blankenhorn DH, Nessim SA, Johnson RI, Sanmaro ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.
3. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary heart disease as a result of intensive therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
4. Kane JP, Mallow M, Prots TA, Phillips NR, Dietil JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
5. Watts GF, Lewis B, Brunt JH, et al. Effects on coronary heart disease of lipid lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992;339:565-9.
6. Blankenhorn DH, Azen SP, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993;119:969-76.
7. Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with an HMG-CoA reductase inhibitor upon the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial (CCAIT). Circulation 1994;89:959-68.
8. Sacks FM, Pasternak RC, Gibson CM, Rosner B, Stone PH. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. The Harvard Atherosclerosis Reversibility Project (HARP). Lancet 1994;344:1182-6.